Clinical Trials Sponsored by Semler Scientific

Total 2252 results

Boston Scientific Corporation

Enrolling by invitation

IT Matters: The Erectile Restoration Registry (It MATTERS)

Erectile Dysfunction

United States
Boston Scientific Corporation

Active, not recruiting

Paresthesia-Free Fast-Acting Subperception (FAST) Study (FAST)

Chronic Pain

United States
Boston Scientific Corporation

Completed

Ranger™ and Ranger™ SL (OTW) DCB) in China

Femoropopliteal Artery Lesions

China
Boston Scientific Corporation

Active, not recruiting

PROMUS PREMIER™ China Post-Approval Study

Coronary Artery Disease

China
Boston Scientific Corporation

Withdrawn

Exalt D Single-use Duodenoscope in ERCP Procedures in China (ExaltDScope)

Cholangiopancreatography
Boston Scientific Corporation

Completed

Jetstream in Treatment of Occlusive Atherosclerotic Lesions in the SFA and/or PPA

Atherosclerosis

China
Boston Scientific Corporation

Active, not recruiting

Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing (MODULAR ATP)

Tachycardia, Ventricular | Arrhythmia, Ventricular

United States, Spain, Italy, United Kingdom, Netherlands, France, Czechia, Austria, Canada
Boston Scientific Corporation

Active, not recruiting

A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) (AGENT IDE)

In-Stent Restenosis

United States
Boston Scientific Corporation

Completed

Ingenio Device Algorithm Study (IVORY)

Heart Failure | AV Block | Sinus Node Disease

Denmark, United Kingdom, Spain, Hong Kong, Netherlands, Sweden, Malaysia, Austria, Belgium, France, Germany, Italy
Boston Scientific Corporation

Active, not recruiting

Intra-operative Pancreatoscopy in Patients With IPMN

Intraductal Papillary Mucinous Neoplasm

United States, Netherlands, China, India, Japan, Sweden
Hipra Scientific, S.L.U

Active, not recruiting

Safety and Immunogenicity of a Booster Vaccination With an Adapted Vaccine

SARS-CoV2 Infection

Spain
Boston Scientific Corporation

Withdrawn

LithoVue Elite Registry (LVE)

Urolithiasis | Kidney Stone
Boston Scientific Corporation

Terminated

Trial for A Novel Facilitated Antegrade Steering Technique in Revascularization of Coronary Chronic Total Occlusions

CAD

China
Boston Scientific Corporation

Completed

Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation (FROZEN-AF)

Paroxysmal Atrial Fibrillation

United States, Hong Kong, Canada, Taiwan, Belgium, France, Germany, Italy, Netherlands
Boston Scientific Corporation

Active, not recruiting

Safety and Effectiveness of Agent Paclitaxel-Coated PTCA Balloon Catheter. (AGENT Japan SV)

Coronary Artery Disease

Japan
Uute Scientific Oy

Active, not recruiting

The Effect of Nature-based Exposure on the Immune System and Skin Health of Atopic Dermatitis Patients.

Atopic Dermatitis

Finland
miR Scientific LLC

Active, not recruiting

Evaluation of the Sentinel™ PCC4 Assay for Diagnosis, Prognosis and Monitoring of Prostate Cancer in Puerto Rico

Prostate Cancer

Puerto Rico
miR Scientific LLC

Active, not recruiting

Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel™ Platform

Prostate Cancer

United States
Boston Scientific Corporation

Completed

Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry (SMART Registry)

Heart Failure

Canada, Spain, United States, Germany, United Kingdom, Australia, Netherlands, Belgium, France, Italy, Portugal, Austria, Czechia, Slovakia, Switzerland
Boston Scientific Corporation

Completed

Data Collection - Of Syncope Tilt Table Testing Study (COST3)

Orthostatic Hypotension | Reflex Syncope

United States
Boston Scientific Corporation

Completed

Deep Brain Stimulation (DBS) for the Treatment of Parkinson's Disease (INTREPID)

Parkinson's Disease

United States
Boston Scientific Corporation

Completed

Postmarket Registry for Evaluation of the Superion® Spacer (PRESS)

Lumbar Spinal Stenosis

United States
Boston Scientific Corporation

Completed

ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent (IMPERIAL)

Atherosclerosis of Native Arteries of the Extremities

New Zealand, United States, Belgium, Canada, Japan, Germany, Austria
Boston Scientific Corporation

Completed

Focal Pain Outcomes Using Configurations Applied for Lateral Stimulation (FOCAL)

Chronic Pain

Belgium
Hipra Scientific, S.L.U

Completed

Assessing the Immunogenicity and Safety of a HIPRA's Candidate Booster Vaccination in Adults Fully Vaccinated With Adenovirus Vaccine Against COVID-19.

COVID-19 | SARS-CoV-2 Acute Respiratory Disease

Spain
Boston Scientific Corporation

Completed

Radiopaque Hydrogel Spacer in Patients Undergoing Radiotherapy for Pancreatic Cancer

Pancreatic Cancer

United States
Boston Scientific Corporation

Completed

AXIOS™ for Gallbladder Drainage as an Alternative to Percutaneous Drainage IDE

Cholecystitis, Acute

United States, Belgium
Boston Scientific Corporation

Terminated

REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects (REPRISE IV)

Aortic Valve Stenosis

United States, Australia
Boston Scientific Corporation

Completed

A Study Evaluating the Safety and Efficacy of BGC20-0582 Lice Treatment Gel for Head Lice Infestation

Head Lice | Pediculus Humanus Capitis

United States
Boston Scientific Corporation

Terminated

Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer

Esophageal Cancer | Squamous Cell Carcinoma | Adenocarcinoma of the Esophagus

United States, India, Czechia, Poland
Boston Scientific Corporation

Active, not recruiting

Observe the Safety and Effectiveness of the WATCHMAN FLX™ for Subjects in Hong Kong

Non-valvular Atrial Fibrillation

China
Boston Scientific Corporation

Completed

Strategic Management to Optimize Response To Cardiac Resynchronization Therapy (SMART CRT)

Heart Failure

United States, United Kingdom, France, Germany, Netherlands, Spain, Ireland, Canada, Japan, Switzerland, Italy
Boston Scientific Corporation

Completed

Continued Access to PREVAIL (CAP2) - WATCHMAN Left Atrial Appendage (LAA) Closure Technology (CAP2)

Atrial Fibrillation

United States
Boston Scientific Corporation

Completed

Post-Approval Study of PROMUS Element™ in China (PEChina)

Coronary Artery Disease

China
Boston Scientific Corporation

Completed

Initial Case Series With Exalt Single-Use Duodenoscope

Endoscopic Retrograde Cholangiopancreatography

United States
Boston Scientific Corporation

Terminated

Fast-Acting Subperception Study (FAST) (FAST)

Chronic Pain

United States
Boston Scientific Corporation

Completed

Combining Mechanisms for Better Outcomes (COMBO) (COMBO)

Back Pain | Chronic Pain

United States
Boston Scientific Corporation

Completed

Effect of VarIthena on Wound Healing in Venous Leg Ulcers (VLU) (VIEW-VLU)

Venous Leg Ulcer

United States, Canada
Boston Scientific Corporation

Completed

RESPOND Post Market Study (RESPOND)

Aortic Valve Stenosis

Spain, Italy, Netherlands, United Kingdom, Germany, Israel, New Zealand, Finland, Sweden, Colombia, Norway, Poland, Switzerland
Boston Scientific Corporation

Completed

To Evaluate the Safety and Efficacy of LithoVue Ureteroscope System in Chinese Patients With Urinary Disease (LithoVue)

Urinary Tract Disease

China
Boston Scientific Corporation

Completed

Observation of ImageReady™ MR Conditional Defibrillation System in China

Arrhythmia

China
Boston Scientific Corporation

Completed

Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED)

Ventricular Fibrillation | Ventricular Tachycardia | Low Cardiac Output

United States, Belgium, Spain, Netherlands, Germany, France, United Kingdom, Canada, Denmark, Italy, Poland, Puerto Rico, Switzerland
Boston Scientific Corporation

Completed

Study of the WallFlex™ Biliary Partially-covered Stent for the Palliative Treatment of Malignant Bile Duct Obstruction

Biliary Strictures Caused by Malignant Neoplasms

Italy, Belgium, France, Germany, India, Netherlands
Boston Scientific Corporation

Completed

Subcutaneous Implantable Defibrillator (S-ICD) System - CE Clinical Investigation

ACC/AHA/NASPE Class 1, IIa or IIb Indications

Netherlands, Italy, United Kingdom, New Zealand
Boston Scientific Corporation

Completed

A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s) (EVOLVE48)

Coronary Artery Disease

United States, United Kingdom, New Zealand, Latvia
Boston Scientific Corporation

Completed

COMFORT: A Multicenter, Open-label, Randomized, Crossover Study (COMFORT)

Varicose Veins

United States
Boston Scientific Corporation

Terminated

Study of Intraparenchymal Therapy With Irinotecan Drug Eluting Beads as Adjunct to Recurrent Surgically Resectable High Grade Glioma (IDEB-glioma)

Glioma

France, Germany
Boston Scientific Corporation

Completed

Polidocanol Endovenous Microfoam (PEM) Versus Vehicle for the Treatment of Saphenofemoral Junction (SFJ) Incompetence (VANISH-2)

Varicose Veins

United States
Boston Scientific Corporation

Completed

Validity of Electronic Diary for Monitoring Varicose Veins Symptoms

Varicose Veins

United Kingdom
Boston Scientific Corporation

Completed

Electronic Repositioning With Acuity and Easytrak Leads (ERACE)

Heart Failure

Germany

Clinical Trials Sponsored by Semler Scientific

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Benin

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations